Under cell stress, such as treatment with trastuzamab in breast cancer cells, or following androgen ablation in prostate cancer cells, significant increase in CLU expression was associated with activation of alternative signaling [62,63]. The gene discussed is CLU; the disease is prostate carcinoma.